Preeclampsia prevention and management

Journal of the Society for Gynecologic Investigation

Volumn 7, Issue 1, 2000, Pages 21-36

  Norwitz, Errol R ^a   Repke, John T ^b  

^a Gynecol   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Aspirin; Calcium; Magnesium sulfate; Management; Preeclampsia; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; CADMIUM; CALCIUM CARBONATE; CHLORPROMAZINE; DIAZEPAM; DIETHAZINE; DIURETIC AGENT; FIBRINOLYTIC AGENT; GLUCONATE CALCIUM; KETANSERIN; MAGNESIUM SULFATE; NITRIC OXIDE DONOR; OZAGREL; PETHIDINE; PHENYTOIN; SELENIUM; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; TRAPIDIL; ZINC;

BED REST; BIOCHEMISTRY; BLOOD CLOTTING DISORDER; CALCIUM INTAKE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; ECLAMPSIA; EDEMA; FEMALE; HUMAN; HYPERTENSION; PATHOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK FACTOR;

FEMALE; HUMANS; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS;

EID: 0033965275     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(99)00050-7     Document Type: Review

References (162)

1. Committee on Obstetrics. Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists Technical Bulletin No. 219. American College of Obstetricians and Gynecologists, 1996.
2. Rochat R.W., Koonin L.M., Atrash J.F. Maternal mortality in the United States Report from the Maternal Morality Collaborative . Obstet Gynecol. 72:1988;91-97.
3. Koonin L.M., Atrash H.K., Rochat R.W., Smith J.C. Maternal mortality surveillance, United States, 1980-1985. MMWR Mor Mortal Wkly Rep CDC Surveill Summ. 37:1988;19-29.
4. Berg C.J., Atrash H.K., Koonin L.M., Tucker M. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol. 88:1996;161-167.
5. Lin C.C., Lindheimer M.D., River P., Moawad A.H. Fetal outcome in hypertensive disorders of pregnancy. Am J Obstet Gynecol. 142:1982;255-260.
6. Boyd P.A., Lindenbaum R.H., Redman C.W.G. Preeclampsia and trisomy 13 A possible association . Lancet. 2:1987;397-399.
7. Chua S., Redman C.W.G. Prognosis for pre-eclampsia complicated by 5 g or more of proteinuria in 24 hours. Eur J Obstet Gynecol Reprod Biol. 43:1992;9-12.
8. Odendaal H.J., Pattinson R.C., Bam R., Grove D., Kotze TJvW. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation A randomized controlled trial . Obstet Gynecol. 76:1990;1070-1074.
9. Sibai B.M., Mercer B.M., Schiff E., Friedman S.A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation A randomized controlled trial . Am J Obstet Gynecol. 171:1994;818-822.
10. Goldstein D.P., Berkowitz R.S. Current management of complete and partial molar pregnancy. J Reprod Med. 39:1994;139-146.
11. Piering W.F., Garancis J.G., Becker C.G., Beres J.A., Lemann J. Preeclampsia related to a functioning extrauterine placenta Report of a case and 25-year follow-up . Am J Kidney Dis. 21:1993;310-313.
12. Aladjem S., Lueck J., Brewer J.I. Experimental induction of a toxemia-like syndrome in the pregnant beagle. Am J Obstet Gynecol. 145:1983;27-38.
13. Yallampalli C., Garfield R.E. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 169:1993;1316-1320.
14. Takimoto E., Ishida J., Sugiyama F., Horiguchi H., Murakami K., Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 274:1996;995-998.
15. Buhimschi I.A., Saade G.R., Chwalisz K., Garfield R.E. The nitric oxide pathway in pre-eclampsia Pathophysiological implications . Hum Reprod Update. 4:1998;25-42.
16. Dekker G.A., Sibai B.M. Etiology and pathogenesis of preeclampsia Current concepts . Am J Obstet Gynecol. 179:1998;1359-1375.
17. Redman C.W.G., Sacks G.P., Sargent I.L. Preeclampsia An excessive maternal inflammatory response to pregnancy . Am J Obstet Gynecol. 180:1999;499-506.
18. Sibai B.M., Ewell M., Levine R.J. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol. 177:1997;1003-1010.
19. Caritis S., Sibai B.M., Hauth J. Predictors of pre-eclampsia in women at high risk. Am J Obstet Gynecol. 179:1998;946-951.
20. Norwitz ER, Robinson JN, Repke JT. Prevention of preeclampsia. Is it possible? In: Sibai BM, ed. Clinical obstetrics and gynecology. Philadelphia: Lippincott, Williams & Wilkins, 1999, 42:436-54.
21. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol. 68:1993;495-532.
22. Alderman B.W., Sperling R.S., Daling J.R. An epidemiological study on the immunogenetic aetiology of pre-eclampsia. BMJ. 292:1986;372-374.
23. Cunningham F.G., Leveno K.J. Management of pregnancy-induced hypertension. Rubin P.C. Handbook of hypertension, Vol X Hypertension in pregnancy . 1988;290 Elsevier Science, Amsterdam.
24. Feeney J.G., Scott J.S. Pre-eclampsia and changed paternity. Eur J Obstet Gynecol Reprod Biol. 11:1980;35-38.
25. Robillard P.-Y., Dekker G.A., Hulsey T.C. Revisiting the epidemiological standard of preeclampsia Primigravidity or primipaternity? Eur J Obstet Gynaecol Reprod Biol. 84:1999;37-41.
26. Robillard P.-Y., Hulsey T.C., Péianin J., Janky E., Miri E.H., Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet. 344:1994;973-975.
27. Clark D.A. Does immunological intercourse prevent pre-eclampsia? [commentary] Lancet. 344:1994;969-970.
28. Klonoff-Cohen H.S., Savitz D.A., Cefalo R.C., McCann M.F. An epidemiologic study of contraception and preeclampsia. JAMA. 262:1989;3143-3147.
29. Chesley L.C., Annitto J.E., Cosgrove R.A. The familial factor in toxemia of pregnancy. Obstet Gynecol. 32:1968;303-311.
30. Chesley L.C., Cooper D.W. Genetics of hypertension in hypertension Possible single gene control pre-eclampsia and eclampsia in the descendents of eclamptic women . Br J Obstet Gynaecol. 93:1986;898-908.
31. Ward K., Hata A., Jeunemaitre X., et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 4:1993;59.
32. Dizon-Townson D.S., Nelson L.M., Easton K., Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol. 175:1996;902-905.
33. Wilcken B., Leung K.C., Hammond J., Kamath R., Leonard J.V. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet. 341:1993;407-408.
34. Thornton J.C., Onwude J.L. Preeclampsia Discordance among identical twins . BMJ. 303:1991;1241-1242.
35. Cnattingius S., Mills J.L., Yuen J., Eriksson O., Ros H.S. The paradoxical effect of smoking in preeclamptic pregnancies Smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction . Am J Obstet Gynecol. 177:1997;156-161.
36. Brosens I.A., Robertson W.B., Dixon H.G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1:1972;177-191.
37. Cross J.C., Werb Z., Fisher S.J. Implantation and the placenta Key pieces of the development puzzle . Science. 266:1994;1508-1518.
38. Pijnenborg R., Robertson W.B., Brosens I., Dixon G. Trophoblast invasion and the establishment of hemochorial placentation in man and laboratory animals. Placenta. 2:1981;71-92.
39. Meekins J.W., Pijnenborg R., Hanssens M., McFadyen I.R., van Assche A. As study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 101:1994;669-674.
40. Zhou Y., Damsky C.H., Chiu K., Roberts J.M., Fisher S.J. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest. 91:1993;950-960.
41. Zhou Y., Damsky C.H., Fisher S.J. Preeclampsia is associated with a failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective invasion in this syndrome? J Clin Invest. 99:1997;2152-2164.
42. Roberts J.M., Edep M.E., Goldfein A., Taylor R.N. Sera from preeclamptic women specifically activate umbilical vein endothelial cells in vitro. Am J Reprod Immunol. 27:1992;101-108.
43. Taylor R.N., Crumbleholme W.R., Friedman S.A., Jones L.A., Casal D.C., Roberts J.M. High plasma cellular fibronectin levels correlate with biochemical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol. 165:1991;895-901.
44. Gaber L.W., Spargo B.H., Lindheimer M.D. Renal pathology in pre-eclampsia. Baillieres Clin Obstet Gynaecol. 8:1994;443-468.
45. Rolfes D.B., Ishak K.G. Liver diseases in toxemia of pregnancy. Am J Gastroenterol. 81:1986;1138-1144.
46. Meekins J.W., Pijnenborg R., Hanssens M., van Assche A., McFadyen I.R. Immunohistochemical detection of lipoprotein(a) in the wall of placental bed spiral arteries in normal and severe pre-eclamptic pregnancies. Placenta. 15:1994;511-524.
47. Salafia C.M., Pezzullo J.C., Ghidini A., Lopez-Zeno J.A., Whittington S.S. Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. Placenta. 19:1998;67-72.
48. De Wolf F., Robertson W.B., Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol. 123:1975;164-174.
49. Holzgreve W., Ghezzi F., Di Naro E., Gänshirt D., Maymon E., Hahn S. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol. 91:1998;669-672.
50. Knight M., Redman C.E., Linton E.A., Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 105:1998;632-640.
51. Gant N.F., Daley G.L., Chand S., Whalley P.J., MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 52:1973;2682-2689.
52. Dekker G.A., Makovitz J.W., Wallenburg H.C.S. Comparison of prediction of pregnancy-induced hypertensive disease by angiotensin II sensitivity and supine pressor test. Br J Obstet Gynaecol. 97:1990;817-821.
53. Tomoda S., Kitanaka T., Ogita S., Hidaka A. Prediction of pregnancy-induced hypertension by isometric exercise. Asia Oceania J Obstet Gynaecol. 20:1994;249-255.
54. Gant N.F., Chand S., Worley R.J., Whalley P.J., Crosby U.D., MacDonald P.C. A clinical test useful for predicting the development of acute hypertension in pregnancy. Am J Obstet Gynecol. 120:1974;1-6.
55. Harrington K., Cooper D., Lees C., Hecher K., Campbell S. Doppler ultrasound of the uterine arteries The importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small for gestational age baby . Ultrasound Obstet Gynecol. 7:1996;182-188.
56. Irion O., Masse J., Forest J.C., Moutquin J.M. Prediction of pre-eclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women. Br J Obstet Gynaecol. 105:1998;422-429.
57. Campbell S., Pearce J.M.F., Hackett G., Cohen-Overbeek T., Hernandez C. Qualitative assessment of uteroplacental blood flow Early screening test for high-risk pregnancies . Obstet Gynecol. 68:1986;649-653.
58. Arduini D., Rizzo G., Romanini C., Mancuso S. Uteroplacental blood flow velocity waveforms as predictors of pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol. 26:1987;335-341.
59. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia An endothelial cell disorder . Am J Obstet Gynecol. 161:1989;1200-1204.
60. Branch D.W., Dudley D.J., La Marche S., Mitchell M.D. Sera from pre-eclamptic women contains factor(s) that stimulate prostacyclin production by human endothelial cells. Prostaglandins Leukot Essent Fatty Acids. 45:1992;191-195.
61. Baker P.N., Davidge S.T., Roberts J.M. Plasma from women with pre-eclampsia increases endothelial cell nitric oxide production. Hypertension. 26:1995;244-248.
62. Davidge S.T., Signorella A.P., Lykins D.L., Gilmour C.H., Roberts J.M. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol. 175:1996;1301-1306.
63. Endresen M.J., Tosti E., Heimli H., Lorentzen B., Henriksen T. Effects of fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand J Clin Lab Invest. 54:1994;549-557.
64. Hubel C.A., McLaughlin M.K., Evans R.W., Hauth B.A., Sims C.J., Roberts J.M. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol. 174:1996;975-982.
65. Vince G.S., Starkey P.M., Austgulen R., Kwiatkowski D., Redman C.W.G. Interleukin-6, tumour necrosis factor and soluble tumour necrosis receptors in women with pre-eclampsia. Br J Obstet Gynaecol. 102:1995;20-25.
66. de Jager C.A., Shepard E.G., Robson S.C., et al. Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia. J Lab Clin Med. 125:1995;522-530.
67. Smarason A.K., Sargent I.L., Starkey P.M., Redman C.W.G. The effect of placental syncytiotrophoblast microvillous membranes from normal and preeclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol. 100:1993;943-949.
68. 2 attenuates the pressor response to angiotensin II in pregnant subjects but not in nonpregnant subjects. Am J Obstet Gynecol. 142:1982;168-176.
69. Friedman S.A. Preeclampsia A review of the role for prostaglandins . Obstet Gynecol. 71:1988;122-137.
70. Lorentzen B., Endresen M.J., Clausen T., Hendriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregn. 13:1994;103-109.
71. Endresen M.J., Lorentzen B., Hendriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol. 167:1992;440-447.
72. Sattar N., Gaw A., Packard C.J., Greer I.A. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia. Br J Obstet Gynaecol. 103:1996;614-620.
73. Sibai B.M. Treatment of hypertension in pregnant women. N Engl J Med. 335:1996;257-265.
74. Lindenstrom E., Boysen G., Nyboe J. Influence of systolic and diastolic blood pressures on stroke risk A prospective observational study . Am J Epidemiol. 142:1995;1279-1290.
75. Lazard E.M. A preliminary report on the intravenous use of magnesium sulfate in puerperal eclampsia. Am J Obstet Gynecol. 9:1925;178-188.
76. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 345:1995;1455-1463.
77. Bhalla A.K., Dhall G.I., Dhall K. A safer and more effective treatment regimen for eclampsia. Aust N Z J Obstet Gynecol. 34:1994;144-148.
78. Dommisse J. Phenytoin sodium and magnesium sulfate in the management of eclampsia. Br J Obstet Gynecol. 97:1990;104-109.
79. Crowther C. Magnesium sulfate versus diazepam in the management of eclampsia A randomized controlled trial . Br J Obstet Gynecol. 97:1990;110-117.
80. Witlin A.G., Sibai B.M. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol. 92:1998;883-889.
81. Lucas M.J., Leveno K.J., Cunningham F.G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 333:1995;201-205.
82. Coetzee E.J., Dommisse J., Anthony J. A randomized controlled trial of intravenous magnesium sulfate versus placebo in the management of women with severe preeclampsia. Br J Obstet Gynecol. 105:1998;300-303.
83. Friedman S.A., Lim K.H., Baker C.A., Repke J.T. Phenytoin versus magnesium sulfate in preeclampsia A pilot study . Am J Perinatol. 10:1993;233-238.
84. Chen F., Chang S., Chu K. Expectant management in severe preeclampsia Does magnesium sulfate prevent the development of eclampsia? Acta Obstet Gynecol Scand. 74:1995;181-185.
85. Belfort M.A., Moise K.J. Effect of magnesium sulfate on maternal brain flow in preeclampsia A randomized, placebo-controlled study . Am J Obstet Gynecol. 167:1992;661-666.
86. Naidu S., Payne A.J., Moodley J., Hoffman M., Gouws E. Randomised study assessing the effect of phenytoin and magnesium sulfate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. Br J Obstet Gynaecol. 103:1996;111-116.
87. Higby K., Xenakis E., Pauerstein C. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol. 168:1993;1247-1259.
88. Cotton D.B., Hallak M., Janusz C., Irtenkauf S.M., Berman R.F. Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. Am J Obstet Gynecol. 168:1993;974-978.
89. Witlin A.G., Friedman S.A., Sibai B.M. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term A randomized, double-blind, placebo-controlled trial . Am J Obstet Gynecol. 176:1997;623-627.
90. Crowther C., Chalmers I. Bed rest and hospitalization during pregnancy. Chalmers I., Enkin M., Keirse M.J.N. Effective care in pregnancy and childbirth. 1989;624-632 Oxford University Press, Oxford.
91. Steegers E.A., Eskes T.K., Jongsma H.W., Hein P.R. Dietary sodium restriction during pregnancy A historical review . Eur J Obstet Gynecol Reprod Biol. 40:1991;83-90.
92. Gratacos E., Casals E., Sanllehy C., Cararach V., Alonso P.L., Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand. 75:1996;896-901.
93. Hubel C.A., McLaughlin M.K., Evans R.W., Hauth B.A., Sims C.J., Roberts J.M. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol. 174:1996;975-982.
94. Mikhail M.S., Anyaegbunam A., Garfinkel D., Palan P.R., Basu J., Romney S.L. Preeclampsia and antioxidant nutrients Decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia . Am J Obstet Gynecol. 171:1994;150-157.
95. Schiff E., Friedman S.A., Stampfer M., Kao L., Barrett P.H., Sibai B.M. Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 175:1996;1024-1028.
96. Olsen S.F., Secher N.J. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia Indications for a 50-year-old controlled trial . Br J Nutr. 64:1990;599-609.
97. Adair C.D., Sanchez-Ramos L., Briones D.L., Ogburn P. Jr. The effect of high dietary n-3 fatty acid supplementation on angiotensin II pressor response in human pregnancy. Am J Obstet Gynecol. 175:1996;688-691.
98. Laivuori H., Hovatta O., Viinikka L., Ylikorkala O. Dietary supplementation with primrose oil or fish oil does not change urinary excretion of prostacyclin and thromboxane metabolites in pre-eclamptic women. Prostaglandins Leukot Essent Fatty Acids. 49:1993;691-694.
99. Salvig J.D., Olsen S.F., Secher N.J. Effects of fish oil supplementation in late pregnancy on blood pressure A randomized controlled trials . Br J Obstet Gynaecol. 103:1996;529-533.
100. Onwude J.L., Lilford R.J., Hjartardottier H., Staines A., Tuffnell D. A randomised double-blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol. 109:1995;95-100.
101. Lazebnik N., Kuhnert B.R., Kuhnert P.M. Zinc, cadmium, and hypertension in parturient women. Am J Obstet Gynecol. 161:1989;437-440.
102. Mohamed K., James D.K., Golding J., McCabe R. Zinc supplementation during pregnancy A double blind randomized clinical trial . BMJ. 299:1989;826-830.
103. Jonsson B., Hauge B., Larsen N.F., Hald F. Zinc supplementation during pregnancy A double blind randomized clinical trial . Acta Obstet Gynaecol Scand. 75:1996;725-729.
104. Sibai B.M., Villar M.A., Bray E. Magnesium supplementation during pregnancy A double blind randomized controlled clinical trial . Am J Obstet Gynecol. 161:1989;115-119.
105. Han L., Zhou S.M. Selenium supplement in the prevention of pregnancy-induced hypertension. Chin Med J. 107:1994;870-871.
106. Lamm C.I., Norton K.I., Murphy R.J., Wilkins I.A., Rabinowitz J.G. Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr. 113:1988;1078-1082.
107. Belizan J.M., Villar J., Repke J.T. The relationship between calcium intake and pregnancy-induce hypertension Up-to-date evidence . Am J Obstet Gynecol. 158:1988;898-902.
108. Seely E.W., Wood R.J., Brown E.M., Graves S.W. Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab. 74:1992;1436-1440.
109. Conde-Agudelo A., Lede R., Belizan J. Evaluation of methods used in the prediction of hypertensive disorders of pregnancy. Obstet Gynecol Surv. 49:1994;210-222.
110. Hatton D.C., McCarron D.A. Dietary calcium and blood pressure in experimental models of hypertension. Hypertension. 23:1994;513-530.
111. Kawasaki N., Matsui K., Masaharu I., Nakamura T., Yoshimura T., Hidetaka U. Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. Am J Obstet Gynecol. 153:1985;576-582.
112. Marya R.K., Rathee S., Manrow M. Effect of calcium and vitamin D supplementation on toxemia of pregnancy. Gynecol Obstet Invest. 24:1987;38-42.
113. Villar J., Repke J.T., Belizan J.M., Pareja G. Calcium supplementation reduces blood pressure during pregnancy Results of a randomized controlled clinical trial . Obstet Gynecol. 70:1987;317-322.
114. Lopez-Jaramillo P., Narvaez M., Weigel R.M., Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol. 96:1989;648-655.
115. Lopez-Jaramillo P., Narvaez M., Felix C., Lopez A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet. 335:1990;293.
116. Villar J., Repke J.T. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol. 163:1990;124-131.
117. Belizan J.M., Villar J., Gonzalez L., Campodonico L., Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med. 325:1991;1399-1405.
118. Cong K.J., Chi S.L., Liu C.R. Calcium and pregnancy induced hypertension. Am J Obstet Gynecol. 28:1993;1-10.
119. Ito M., Koyama H., Ohshige A., Maeda T., Yoshimura T., Okamura H. Prevention of preeclampsia with calcium supplementation and vitamin D3 in an antenatal protocol. Int J Gynaecol Obstet. 47:1994;115-120.
120. Sanchez-Ramos L., Briones D.K., Kaunitz A.M., et al. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol. 84:1994;349-353.
121. Purwar M., Kulkarni H., Motghare V., et al. Calcium supplementation and prevention of pregnancy induced hypertension. J Obstet Gynaecol Res. 22:1996;425-430.
122. Lopez-Jaramillo P., Delgado F., Jacome P., et al. Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstet Gynecol. 90:1997;162-167.
123. Levine R.J., Hauth J.C., Curt L.B., et al. Trial of calcium to prevent preeclampsia. N Engl J Med. 337:1997;69-76.
124. Herrera J.A., Arevalo-Herrera M., Herrera S. Prevention of preeclampsia by linoleic acid and calcium supplementation A randomized controlled trial . Obstet Gynecol. 91:1998;585-590.
125. Crowther C.A., Hillier J.E., Pridmore B., Bryce R., Duggan P., Hague W.M., Robinson J.S. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia, and preterm birth An Australian randomized trial. FRACOG and the ACT Study Group . Aust N Z J Obstet Gynaecol. 39:1999;12-18.
126. Carroli G., Duley L., Belzian J.M., Villar J. Calcium supplementation during pregnancy A systematic review of randomized controlled trials . Br J Obstet Gynaecol. 101:1994;753-758.
127. Bucher H., Guyatt G.H., Cook R.J., et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia A meta-analysis of randomized controlled trials . JAMA. 275:1996;1113-1117.
128. Levine R.J., Esterlitz J.R., Raymond E.G., et al. Rationale, design, and methods . Control Clin Trials. 17:1996;442-469.
129. Levine R.J., DerSimonian R. Effects of calcium supplementation on pregnancy-induced hypertension. JAMA. 276:1996;1387.
130. Richardson B.E., Baird D.D. A study of milk and calcium supplement intake and subsequent preeclampsia in a cohort of pregnant women. Am J Epidemiol. 141:1995;667-673.
131. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 336:1997;1117-1124.
132. Collins R., Yusuf S., Peto R. Overview of randomised trials of diuretics in pregnancy. BMJ. 290:1985;17-23.
133. Wang Y., Walsh S.W. Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas. Free Radic Biol Med. 18:1995;585-591.
134. Beaufils M., Uzan S., Donsimoni R., Colau J.C. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. i:1985;840-842.
135. Wallenburg H.C.S., Dekker G.A., Makovitz J.W., Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. i:1986;1-3.
136. 2 to prostacyclin in relatively high risk pregnancies. N Engl J Med. 321:1989;351-356.
137. Benigni A., Gregorini G., Frusca T., et al. Effect of low dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med. 321:1989;357-362.
138. McParland P., Pearce J.M., Chamberlain G.V.P. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet. 335:1990;1552-1555.
139. Uzan S., Beaufils M., Breart G., Bazin B., Capitant C., Paris J. Prevention of fetal growth retardation with low-dose aspirin: Findings of the EPRENA trial. Lancet. 337:1991;1427-1431.
140. Hauth J.C., Goldenberg R.L., Parker C.R. Jr, et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol. 168:1993;1083-1093.
141. Imperiale T.F., Petrulis A.S. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA. 266:1991;261-264.
142. Dekker G.A., Sibai B.M. Low-dose aspirin The prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials . Am J Obstet Gynecol. 168:1993;214-227.
143. Viinikka L., Hartikainen-Sorri A.L., Lumme R., Hiilesmaa V., Ylikorkala O. Low dose aspirin in hypertensive pregnant women Effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn . Br J Obstet Gynaecol. 100:1993;809-815.
144. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet. 341:1993;396-400.
145. Sibai B.M., Caritis S.N., Thom E., et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med. 329:1993;1213-1218.
146. CLASP A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women . Lancet. 343:1994;619-629.
147. Wang Z., Li W. A prospective randomized placebo-controlled trial of low-dose aspirin for prevention of intra-uterine growth retardation. Chin Med J Engl. 109:1996;238-242.
148. ECPPA Randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women . Br J Obstet Gynaecol. 103:1996;39-47.
149. Golding J. A randomised trial of low dose aspirin for primiparae in pregnancy. Br J Obstet Gynaecol. 105:1998;293-299.
150. Rotchell Y.E., Cruickshank J.K., Phillips-Gay M., et al. A randomised trial for the prevention of pre-eclampsia and its complications . Br J Obstet Gynaecol. 105:1998;286-292.
151. Byaruhanga R.N., Chipato T., Rusakaniko S. A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia. Int J Gynaecol Obstet. 60:1998;129-135.
152. Caritis S., Sibai B.M., Hauth J., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med. 338:1998;701-705.
153. Hermida C., Ayala D.E., Iglesias M., et al. Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension. 30:1997;589-595.
154. Brenner B., Shapira A., Bahari C., Haimovich L., Seligsohn U. Hereditary protein C deficiency during pregnancy. Am J Obstet Gynecol. 157:1987;1160-1161.
155. Howie P.W., Prentice C.R., Forbes C.D. Failure of heparin therapy to affect the clinical course of severe pre-eclampsia. Br J Obstet Gynaecol. 82:1975;711-717.
156. North R.A., Ferrier C., Gamble G., et al. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust N Z J Obstet Gynaecol. 35:1995;357-362.
157. Riyazi N., Leeda M., de Vries J.I., Huijgens P.C., van Geijn H.P., Dekker G.A. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction A preliminary study . Eur J Obstet Gynecol Reprod Biol. 80:1998;49-54.
158. Nobunaga T., Tokugawa Y., Hashimoto K., et al. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest. 41:1996;189-193.
159. Oyelese K.O., Black R.S., Lees C.C., Campbell S. A novel approach to the management of pregnancies complicated by uteroplacental insufficiency and previous stillbirth. Aust N Z J Obstet Gynaecol. 38:1998;391-395.
160. 2 synthase inhibitor, ozagrel, for the treatment and prevention of preeclampsia A preliminary report . J Obstet Gynaecol. 21:1995;357-365.
161. Nieder J., Claus P., Augustin W. Untersuchungen uber den einfluss von trapidil zur pravention von praeklampsie und fetaler retardierung [Effect of trapidil in prevention of pre-eclampsia and fetal growth retardation]. Zentralbl Gynakol. 117:1995;23-28.
162. Steyn D.W., Odendaal H.J. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet. 350:1997;1267-1271.